Social-cognitive aspects of underserved Latinas preparing to undergo genetic cancer risk assessment for hereditary breast and ovarian cancer

Psycho-Oncology

Volumn 17, Issue 8, 2008, Pages 774-782

  Lagos, Veronica I ^a   Perez, Martin A ^a   Ricker, Charité N ^a,c   Blazer, Kathleen R ^a   Santiago, Nydia M ^a   Feldman, Nancy ^b   Viveros, Lori ^b   Weitzel, Jeffrey N ^a  

^a Department of Clinical Cancer Genetics ^*  (United States)

^b OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

BRCA; Cancer; Genetic counseling; Latina; Oncology

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURAL FACTOR; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HISPANIC; HUMAN; MEDICALLY UNDERSERVED; OVARY CANCER; PATIENT REFERRAL; RISK ASSESSMENT; RISK MANAGEMENT; SELF CONCEPT; SOCIAL PSYCHOLOGY; SOCIAL STATUS; SOCIAL SUPPORT;

ACCULTURATION; ADULT; AGED; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENETIC COUNSELING; GENETIC SCREENING; HISPANIC AMERICANS; HUMANS; MEDICALLY UNDERSERVED AREA; MIDDLE AGED; OVARIAN NEOPLASMS; PREVALENCE; PSYCHOLOGY; QUESTIONNAIRES; RISK ASSESSMENT; SELF EFFICACY; SOCIAL PERCEPTION; SOCIAL SUPPORT; UNITED STATES;

EID: 51649095957     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1358     Document Type: Article

References (75)

1. ACS, Cancer Facts & Figures for Hispanics/Latinos 2006-2008. American Cancer Society: Atlanta, GA, 2006.
2. Shavers VL, Harlan LC, Stevens JL. Racial/ethnic variation in clinical presentation, treatment, survival among breast cancer patients under age 35. Cancer 2003;97(1):134-147.
3. Huerta EE. Cancer statistics for Hispanics, 2003: Good news, bad news, and the need for a health system paradigm change. CA A Cancer J Clin 2003;53(4): 205-207.
4. Ford D, Easton DF, Stratton M et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998;62: 676-689.
5. Weitzel JN, Lagos V, Blazer KR et al. Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 2005;14:1666-1671.
6. Hoffman LK. Race and cancer genetics: lessons from BRCA1. Oncology (Huntingt) 2002;16(1):108-112; discussion 113, 118-119.
7. Tang NL, Choy KW, Pang CP et al. Prevalence of breast cancer predisposition gene mutations in Chinese women and guidelines for genetic testing. Clin Chim Acta 2001;313(1-2):179-185.
8. Liede A, Narod SA. Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. Hum Mutat 2002; 20(6):413-424.
9. Ah Mew N, Hamel N, Galvez M et al. Haplotype analysis of a BRCA1: 185delAG mutation in a Chilean family supports its Ashkenazi origins. Clin Genet 2002; 62(2):151-156.
10. Llort G, Munoz CY, Tuser MP et al. Low frequency of recurrent BRCA1 and BRCA2 mutations in Spain. Hum Mutat 2002; 19(3):307.
11. Diez O, Cortes J, Domenech M et al. BRCA1 mutation analysis in 83 Spanish breast and breast/ovarian cancer families. Intl J Cancer 1999;83(4):465-469.
12. Gao Q, Tomlinson G, Das S et al. Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer. Hum Genet 2000;107(2):186-191.
13. Olopade OI, Fackenthal JD, Dunston G et al. Breast cancer genetics in African Americans. Cancer 2003;97 (1 Suppl):236-245.
14. Olopade O. Genetics in clinical cancer care: a promise unfulfilled among minority populations. Cancer Epidemiol Biomarkers Prev 2004; 13(11):1683-1686.
15. Pal T, Permuth-Wey I, Holtje T et al. BRCA1 and BRCA2 Mutations in a Study of African American Breast Cancer Patients. Cancer Epidemiol Biomarkers Prev 2004;13(11):1794-1799.
16. Hughes C, Lerman C, and Lustbader E. Ethnic differences in risk perception among women at increased risk for breast cancer. Breast Cancer Res Treat 1996; 40(1):25-35.
17. Hughes C, Gomez-Caminero A, Benkendorf J et al. Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns 1997;32(1-2):51-62.
18. Lerman C, Hughes C, Benkendorf JL et al. Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiol Biomarkers Prev 1999;8: 361-367.
19. Thompson HS, Valdimarsdottir HB, Duteau-Buck C et al. Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. Cancer Epidemiol Biomarkers Prev 2002; 11(12): 1579-1585.
20. Kinney AY, Bloor LE, Mandal D et al. The impact of receiving genetic test results on general and cancer-specific psychologic distress among members of an African-American kindred with a BRCA1 mutation. Cancer 2005;104(11):2508-2516.
21. Vadaparampil ST, Wideroff L, Breen N et al. The impact of acculturation on awareness of genetic testing for increased cancer risk among Hispanics in the Year 2000 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2006;15(4):618-623.
22. Honda K. Who gets the information about genetic testing for cancer risk? The role of race/ethnicity, immigration status, and primary care clinicians. Clin Genet 2003;64(2):131-136.
23. Ramirez AG, Aparicio-Ting FE, de Majors SS et al. Interest, awareness, and perceptions of genetic testing among Hispanic family members of breast cancer survivors. Ethn Dis 2006; 16(2):398-403.
24. Thompson HS, Valdimarsdottir HB, Jandorf L et al. Perceived disadvantages and concerns about abuses of genetic testing for cancer risk: differences across African American, Latina and Caucasian women. Patient Educ Couns 2003;51(3):217-227.
25. Ricker CN, Hiyama S, Fuentes S et al. Beliefs and Interest in Cancer Risk in an Underserved Latino Cohort. Prev Med 2007; 44(3):241-245.
26. Ricker C, Lagos V, Feldman N et al. If we build it... will they come? - Establishing a cancer genetics services clinic for an underserved predominantly Latina cohort. J Genet Couns 2006; 15(6):505-514.
27. ASCO. American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility. J Clin Oncol 2003; 21(12):2397-2406.
28. Fries MH, Holt C, Carpenter I et al. Guidelines for evaluation of patients at risk for inherited breast and ovarian cancer: recommendations of the Department of Defense Familial Breast/Ovarian Cancer Research Project. Mil Med 2002;167(2):93-98.
29. ACMG, Genetic susceptibility to breast and ovarian cancer: assessment, counseling and testing guidelines executive summary/American College of Medical Genetics Foundation. American College of Medical Genetics: New York, 1999.
30. McKinnon WC, Baty BJ, Bennett RL et al. Predisposition genetic testing for late-onset disorders in adults. A position paper of the National Society of Genetic Counselors. J Am Med Assoc 1997; 278: 1217-1220.
31. Eng C, Hampel H, de la Chapelle A. Genetic Testing for Cancer Predisposition. Annu Rev Med 2001; 52:371-400.
32. Daly MB, Axibund JE, Bryant E et al. NCCN Practice Guidelines in Oncology: Genetic/familial high-risk assessment: breast and ovarian. v.1.2007. Rockledge, PA: National Comprehensive Cancer Network, 2007. Available from: http://www.nccn.org/professionals/physician_gls/PDF/ genetics_screening.pdf [cited 2007 March 22].
33. Miller SM, Shoda Y, and Hurley K. Applying cognitive-social theory to health-protective behavior: breast self-examination in cancer screening. Psychol Bull 1996; 119(1):70-94.
34. Rogers LQ, Shah P. Dunnington G et al. Social cognitive theory and physical activity during breast cancer treatment. Oncol Nurs Forum 2005;32(4): 807-815.
35. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 1977;84(2):191-215.
36. Bandura A. Self-efficacy: the exercise of control. Freeman: New York, 1997.
37. DeVellis BM, DeVellis RF. Self-Efficacy and Health. In Handbook of health psychology, Baum A, Revenson TA, and Singer JE (eds). Lawrence Erlbaum Associates: Mahwah, NJ, 2002;235-247.
38. Kohler CL, Fish L, Greene PG. The relationship of perceived self-efficacy to quality of life in chronic obstructive pulmonary disease. Health Psychol 2002; 21(6):610-614.
39. Bennett SE, Lawrence RS, Fleischmann KH et al. Profile of women practicing breast self-examination. J Am Med Assoc 1983; 249(4):488-491.
40. Fletcher SW, Morgan TM, O'Malley MS et al. Is breast self-examination predicted by knowledge, attitudes, beliefs, or sociodemographic characteristics? Am J Prev Med 1989; 5(4):207-215.
41. Shepperd SL, Solomon LJ, Atkins E et al. Determinants of breast self-examination among women of lower income and lower education. J Behav Med 1990;13(4): 359-371.
42. Duffy ME, Rossow R, Herandez M. Correlates of health-promotion activities in employed Mexican American women. Nurs Res 1996; 45(1):18-24.
43. Weitzel MH Waller PR. Predictive factors for health-promotive behaviors in white, Hispanic, and black blue-collar workers. Fam Community Health 1990; 13(1):23-34.
44. Carlsson AH, Bjorvatn C, Engebretsen LF et al. Psychosocial factors associated with quality of life among individuals attending genetic counseling for hereditary cancer. J Genet Couns 2004; 13(5):425-445.
45. Gonzalez JT. Factors relating to frequency of breast self-examination among low-income Mexican American women. Implications for nursing practice. Cancer Nurs 1990;13(3):134-142.
46. Maxwell MB. The use of social networks to help cancer patients maximize support. Cancer Nurs 1982;5(4): 275-281.
47. Phillips JM, Wilbur J. Adherence to breast cancer screening guidelines among African-American women of differing employment status. Cancer Nurs 1995;18(4): 258-269.
48. Wagle A, Komorita NI, Lu ZJ. Social support and breast self-examination. Cancer Nurs 1997;20(1): 42-48.
49. Lierman LM, Young HM, Powell-Cope G et al. Using social support to promote breast self-examination performance. Oncol Nurs Forum 1994;21(6): 1051-1056; discussion 1057.
50. Katapodi MC, Facione NC, Miaskowski C et al. The influence of social support on breast cancer screening in a multicultural community sample. Oncol Nurs Forum 2002;29(5):845-852.
51. Suarez L. Pap smear and mammogram screening in Mexican-American women: the effects of acculturation. Am J Public Health 1994; 84(5):742-746.
52. Padilla AM. Notes on the history of Hispanic psychology. Hisp J of Behav Sci 1980;2:109-128.
53. Castro FG, Furth P, Karlow H. The health beliefs of Mexican, Mexican American, and Anglo American women. Hisp J Behav Sci 1984; 6:365-383.
54. Ross CE, Mirowsky J, Cockerham WC. Social class, Mexican culture, and fatalism: their effects on psychological distress. Am J Community Psychol 1983;11(4): 383-399.
55. Meyerowitz BE, Richardson J, Hudson S et al. Ethnicity and cancer outcomes: behavioral and psychosocial considerations. Psychol Bull 1998;123(1):47-70.
56. Perez-Stable EJ, Sabogal F, Otero-Sabogal R et al. Misconceptions about cancer among Latinos and Anglos. J Am Med Assoc 1992; 268(22):3219-3223.
57. Lee MC. Knowledge, barriers, and motivators related to cervical cancer screening among Korean-American women. A focus group approach. Cancer Nurs 2000; 23(3):168-175.
58. Mayo RM, Ureda JR, Parker VG. Importance of fatalism in understanding mammography screening in rural elderly women. J Women Aging 2001;13(1):57-72.
59. Powe BD, Weinrich S. An intervention to decrease cancer fatalism among rural elders. Oncol Nurs Forum 1999;26(3):583-588.
60. Peragallo NP, Fox PG, Alba ML. Acculturation and breast self-examination among immigrant Latina women in the USA. Int Nurs Rev 2000; 47(1):38-45.
61. O'Malley AS, Kerner J, Johnson AE et al. Acculturation and breast cancer screening among Hispanic women in New York City. Am J Public Health 1999; 89(2):219-227.
62. Suarez L, Pulley L. Comparing acculturation scales and their relationship to cancer screening among older Mexican-American women. J Natl Cancer Inst Monogr 1995;18:41-47.
63. Stein JA, Fox SA. Language preference as an indicator of mammography use among Hispanic women. J Natl Cancer Inst 1990; 82(21):1715-1716.
64. Marin G, Sabogal F, VanOss Marin B et al. Development of a Short Acculturation Scale for Hispanics. Hisp J Behav Sci 1987; 9(2):183-203.
65. Powe BD. Fatalism among elderly African Americans. Effects on colorectal cancer screening. Cancer Nurs 1995;18(5):385-392.
66. Tabachnik BG, Fidel LS. Using multivariate statistics (2nd edn). Harper Collins: New York, 1989.
67. Mamon JA, Zapka JG. Determining validity of measuring the quality of breast self-examination; comparison of self-reporting with observed demonstration. Eval Health Prof 1985;8:55-58.
68. Thomas DB, Gao DL, Ray RM et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002;94(19):1445-1457.
69. Harvey BJ, Miller AB, Baines CJ et al. Effect of breast self-examination techniques on the risk of death from breast cancer. Can Med Assoc J 1997;157(9):1205-1212.
70. Warner E, Plewes DB, Hill KA et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. J Am Med Assoc 2004; 292(11):1317-1325.
71. Cuellar I, Harris LC, Jazzo R. An acculturation scale for Mexican-American normal and clinical populations. Hisp J Behav Sci 1980;2(3):199-217.
72. Kessler L, Collier A, Brewster K et al. Attitudes about genetic testing and genetic testing intentions in African American women at increased risk for hereditary breast cancer. Genet Med 2005; 7(4):230-238.
73. Hughes C, Fasaye GA, LaSalle VH et al. Sociocultural influences on participation in genetic risk assessment and testing among African American women. Patient Educ Couns 2003;51(2):107-114.
74. Abraido-Lanza AF, Viladrich A, Florez KR et al. Commentary: Fatalismo Reconsidered: A Cautionary Note For Health-Related Research and Practice with Latino Populations. Ethn Dis 2007; 17(1):153-158.
75. Charles S, Kessler L, Stopfer JE et al. Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American women. Patient Educ Couns 2006;63(1-2):196-204.